Journal News

A p-value for proteins

Pearce Hyatt
By Pearce Hyatt
March 18, 2026

Scientists take the power of a p-value for granted. With a simple threshold, researchers can determine whether an observation is likely due to chance. By contrast, determining significance in proteomics has been more challenging. Searching for new proteins in the literature often produces false positives, and existing search engines cannot reliably filter results.

Tsuyoshi Tabata, Yasushi Ishihama and a team of researchers at Kyoto University created a new solution to searching through proteomic information: UniScore. They published these results in Molecular & Cellular Proteomics.

UniScore uses a target-decoy approach to filter false positives. It compares one dataset of real proteomic information with another created from shuffled protein results as a decoy. This allows researchers to compare matches to true versus fictitious data and calculate the false discovery rate.

Researchers can then set thresholds for acceptable false-positive rates, providing a clear benchmark for analyzing proteomic results. UniScore outperformed traditional search engines, demonstrating that it is a powerful tool for proteomic research moving forward.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Pearce Hyatt
Pearce Hyatt

Pearce Hyatt is an incoming medical student at Wake Forest School of Medicine. He spent two years working at the Laboratory of Viral Diseases at the National Institutes of Health and is an ASBMB Today volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Novel inhibitor targets RAS-driven cancers
Journal News

Novel inhibitor targets RAS-driven cancers

April 7, 2026

Researchers in Louisville identify a small-molecule drug that blocks RALGEF signaling downstream of mutant RAS. The compound suppresses tumor growth with low toxicity, revealing a new therapeutic strategy for RAS-driven malignancies.

Catching tau in the act
Journal News

Catching tau in the act

April 2, 2026

Using a new proximity-labeling approach, researchers reveal how tangles of the brain-associated protein tau may disrupt RNA biology long before neurons die.

How copper delivery fuels bacterial respiration
Journal News

How copper delivery fuels bacterial respiration

April 1, 2026

Researchers identify the roles of several proteins in copper homeostasis in the aerobic bacterium Caulobacter vibrioides.

Revealing the glycoproteome of a cancer subtype
Journal News

Revealing the glycoproteome of a cancer subtype

March 31, 2026

Researchers mapped the glycoproteome of extrahepatic cholangiocarcinoma and compared it to intrahepatic tumors. Differences in sugar modifications and immune cell content suggest new biomarkers and guide development of targeted immunotherapies.

Uncovering the mechanisms of a glycosylation disorder
Journal News

Uncovering the mechanisms of a glycosylation disorder

March 27, 2026

Mutations in OGT, an enzyme that adds sugars to proteins, cause a rare neurological disorder. Using proteomics, researchers reveal how OGT interactions with TET proteins may trigger epigenetic changes and early neural defects.

Heat shock proteins as a promising breast cancer therapeutic
Journal News

Heat shock proteins as a promising breast cancer therapeutic

March 25, 2026

Researchers unveiled isoform-specific targets on heat shock protein 90 which may be beneficial in therapeutic development.